CAMBRIDGE, MA / ACCESS Newswire / May 12, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked no. 1 on TIME's 2026 list of the World's Most Impactful Companies. The recognition highlights ...
The hantavirus outbreak on the MV Hondius poses an ‘extremely low’ overall risk to the public, health officials said ...
A localized outbreak, even a fatal one, is unlikely to spark the multibillion-dollar revenue catalyst that Moderna needs.
The head of the Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that drew months of ...
The Street-high price target of $38 suggests it could nearly triple from here over the next 12 months. 3M stock also emerges ...
Several research groups and pharmaceutical companies had already been studying hantaviruses before the MV Hondius outbreak ...
The resignation ends Dr. Marty Makary's management of the Food and Drug Administration, which was marked by turmoil and ...
Cruise ship outbreak: Three deaths and multiple cases of the Andes strain have been linked to the MV Hondius cruise ship, prompting global health monitoring. Moderna's research role: The company has ...
SUPRAME Phase 3 interim and final analysis for PRAME cell therapy, anzu-cel, expected to be triggered in 2026, advancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results